Search

everythinglearnresearchcommunity

for

Search:↓

N1-methylspermidine helps hair growth and reduces inflammation in hair follicles.

Cytotoxic T cells cause hair loss in chronic alopecia areata.

FGF21 can help reduce skin inflammation caused by C. acnes.

Acanthus ebracteatus Vahl. extract and verbascoside may help prevent hair loss and promote hair growth due to their anti-inflammatory properties and ability to protect against cell death.

Collagen from tilapia scales may improve hair and skin health by reducing stress and inflammation and encouraging hair growth.

Hair loss in men may be caused by inflammation triggered by hormones, and treatments reducing inflammation could potentially promote hair growth.

NMN could potentially treat hair loss by reducing oxidative stress and improving cell health.

People with lower levels of free testosterone tend to have worse COVID-19 outcomes.

Papulopustular rosacea is an inflammatory skin condition treatable with lifestyle changes and medications.

Allopregnanolone can reduce gut inflammation and normalize neurotransmitter levels after finasteride withdrawal.

Some treatments for autoimmune hair loss work, but JAK inhibitors like tofacitinib are promising for regrowth.

Lupus affects the skin in various ways, and proper skin examination is crucial for diagnosis and treatment.

Hair shedding after COVID-19 is more linked to the disease's severity and inflammation rather than hormones, with women at higher risk.

Certain cancer drugs interact with skin bacteria to cause acne-like rashes.

The research suggests immune system changes and specific gene expression may contribute to male hair loss, proposing potential new treatments.

The JAK/STAT pathway is important in cell processes and disease, and JAK inhibitors are promising for treating related conditions.

Oxidative stress plays a significant role in alopecia areata, and new treatments may include JAK inhibitors and antioxidants.

Baricitinib combined with other immune therapies may safely and effectively treat severe scalp hair loss.

A new carrier improves skin delivery of tofacitinib for treating inflammatory skin diseases.

Changes in gut bacteria can contribute to the development of Polycystic Ovary Syndrome (PCOS), affecting metabolism, immunity, and causing inflammation. Treatments may involve adjusting these factors.

Alopecia Areata is treated with drugs and therapies to reduce inflammation and immune response.

The document concludes that new treatments for skin conditions are complex but effective, including spironolactone for female hair loss and propranolol for infantile hemangiomas.

Proteasome inhibitors are promising treatments for various cancers, autoimmune diseases, and other conditions.

Equisetum debile extract, especially the ethyl acetate type, may be a promising natural ingredient for anti-hair loss products.

Leflunomide and anthralin may effectively treat severe alopecia areata.

IL-36α helps grow new hair follicles and speeds up wound healing.

IL-33 is linked to hair follicle damage in psoriasis and could be a treatment target for hair loss in this condition.

Blocking IL-17 can reduce skin inflammation in a mouse model of pityriasis rubra pilaris.

Targeting the IL-23/IL-17 pathway effectively treats several inflammatory skin diseases.

Both ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata, but relapses are common.